Loading...

Kyowa Kirin Co., Ltd.

4151.TJPX
HealthcareDrug Manufacturers - General
¥2434.00
¥-31.00(-1.26%)

Kyowa Kirin Co., Ltd. 4151.T Peers

See (4151.T) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - General Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
4151.T¥2,434.00-1.26%1.3T24.94¥97.58+2.38%
4519.T¥7,619.00+3.91%12.5T30.61¥248.90+1.29%
4568.T¥3,485.00-1.78%6.5T22.37¥155.76+1.72%
4578.T¥6,778.00-1.48%3.5T10.43¥649.65+1.77%
4503.T¥1,396.00+0.04%2.5T49.31¥28.31+5.30%
4528.T¥1,501.50-0.96%705.4B14.11¥106.42+5.33%
4536.T¥1,614.00+0.19%551B15.56¥103.75+2.23%
4552.T¥570.00-3.39%69.4B-14.84-¥38.41+3.51%
4882.T¥427.00-5.11%6.3B-5.64-¥75.74N/A
4550.T¥1,714.00+0.23%00.00¥105,444,448.00N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

4151.T vs 4519.T Comparison

4151.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 4151.T stands at 1.3T. In comparison, 4519.T has a market cap of 12.5T. Regarding current trading prices, 4151.T is priced at ¥2,434.00, while 4519.T trades at ¥7,619.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

4151.T currently has a P/E ratio of 24.94, whereas 4519.T's P/E ratio is 30.61. In terms of profitability, 4151.T's ROE is +0.06%, compared to 4519.T's ROE of +0.22%. Regarding short-term risk, 4151.T is more volatile compared to 4519.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4151.T.

Stock Price Comparison

Loading...

Frequently Asked Questions